Belite Bio, Inc. (NASDAQ:BLTE) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ET Company Participants Julie Fallon - Investor Relations Tom Lin - Chairman and Chief Executive Officer Nathan Mata - Chief Scientific Officer Hendrik Scholl - Chief Medical Officer Hao-Yuan Chuang - Chief Financial Officer Conference Call Participants Jennifer Kim - Cantor Basma Radwan - Leerink Partners Yi Chen - H.C. Wainwright Bruce Jackson - Benchmark Michael Okunewitch - Maxim Group Operator Ladies and gentlemen, th ...